Kelly L. Garvin, BSN, RN, OCN, discusses what changes she hopes to see in CAR T-Cell therapy treatment over the coming years.
Kelly L. Garvin, BSN, RN, OCN
Advertisement
Articles by Kelly L. Garvin, BSN, RN, OCN
Proper training can help oncology nurses act as intensivists and quickly identify if their patients are experiencing any CAR T-cell therapy-related adverse events.
Advertisement
Latest Updated Articles
Expert Weighs in on Future of CAR T-Cell Therapy Treatment DirectionsPublished: August 18th 2021 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
T-DXd Plus Pertuzumab Sustains PFS Benefit Across HER2+ BC Subgroups
2
Sacituzumab Govitecan/Pembro Maintains QOL, Physical Functioning in mTNBC
3
VCN-01 Plus SOC Improves Survival, Is Safe in Metastatic PDAC
4
Operationalizing SubQ Immune Checkpoint Inhibitors in Clinical Practice
5
